BAX and B-cell chronic lymphocytic leukemia: Hence, microenvironmentally activated CLL cells (CD69Pos) that overexpress multiple antiapoptotic proteins could exhibit resistance to a series of proapoptotic agents as a result of insufficient activation of Bax/Bak proteins.